Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on methylation & mthfr. Browse all Methylation & MTHFR education
Methylation is one of the most important chemical processes in your body — it switches genes on and off, builds neurotransmitters, and helps recycle homocysteine. The AHCY gene sits at a critical control point in that cycle. When AHCY variants slow this enzyme, the whole methylation system can back up, with effects that ripple across many pathways.
What AHCY does in the methylation cycle
AHCY encodes S-adenosylhomocysteine hydrolase, the only enzyme that breaks down S-adenosylhomocysteine (SAH). Here is why that is pivotal: SAH is a byproduct made every time a methyl group is transferred, and SAH is also a powerful brake on methylation. If AHCY cannot clear SAH efficiently, SAH builds up and shuts down methyltransferases across the body. AHCY is the enzyme that keeps the methylation cycle moving forward rather than stalling.
The SAM-to-SAH ratio, your methylation index
Methylation capacity is often summarized by the ratio of S-adenosylmethionine (SAM, the methyl donor) to SAH (the inhibitor). A high SAM-to-SAH ratio means methylation runs smoothly; a low ratio means it is suppressed. Because AHCY controls SAH clearance, AHCY variants directly influence this ratio. When the ratio falls, everything downstream — DNA methylation, creatine synthesis, phospholipid production, and neurotransmitter processing — can be affected at once.
Health issues linked to AHCY variants
Rare pathogenic AHCY mutations cause hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency, a serious inherited condition featuring elevated methionine and SAH, developmental effects, and muscle and liver involvement. More common, milder AHCY variants are studied for subtler influences on homocysteine handling and methylation efficiency. Because methylation touches so many systems, reduced AHCY activity is examined in the context of cardiovascular, neurological, and detoxification pathways — always as associations, not certainties.
AHCY does not act alone
AHCY works alongside the rest of the methylation and homocysteine machinery. MTHFR regenerates the folate form needed to remethylate homocysteine, MTR and MTRR run that remethylation step, and CBS routes homocysteine toward clearance. A slow AHCY variant carried alongside a reduced-function MTHFR variant can compound the effect on the cycle. This is why methylation is best read as a pathway, not a single gene.
Supporting methylation without overclaiming
You cannot change your AHCY genotype, but methylation biology responds to inputs. Adequate B vitamins (folate, B12, B6, B2), sufficient protein, and managing alcohol intake all interact with these pathways. The right approach is individualized and belongs in a conversation with a qualified provider, who can order the relevant labs — such as homocysteine — and interpret them alongside your genetics rather than acting on a genotype in isolation.
Where PlexusDx fits
The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including methylation-cycle genes like AHCY and MTHFR. It provides pathway-level context — tendencies to explore with a provider — not a diagnosis or treatment plan. PlexusDx tells you about your biology; it does not tell you what to put in your body. Results are delivered through the secure Results Portal.
Frequently Asked Questions
What does the AHCY gene do?
AHCY makes S-adenosylhomocysteine hydrolase, the enzyme that clears SAH from the methylation cycle. Because SAH inhibits methylation, clearing it keeps the cycle running. Variants that slow AHCY can raise SAH, lower the SAM-to-SAH ratio, and reduce overall methylation efficiency across many downstream pathways in the body.
Are AHCY variants dangerous?
Rare pathogenic AHCY mutations cause a serious inherited metabolic disorder, but these are uncommon. More frequent, milder variants are studied for subtler effects on methylation and homocysteine. A variant is a tendency, not a diagnosis; only a qualified provider can interpret its significance for your individual health.
Can I fix a slow AHCY variant?
You cannot change the genotype itself, but methylation pathways respond to inputs like adequate folate, B12, B6, and B2, sufficient protein, and moderated alcohol. The right plan is individualized. A provider can order homocysteine and related labs and interpret them alongside your genetics before recommending anything.
How is AHCY related to MTHFR?
Both sit in the same methylation and homocysteine cycle. MTHFR helps regenerate the folate needed to remethylate homocysteine, while AHCY clears the SAH that inhibits methylation. A reduced-function variant in each can compound the other, which is why methylation is best assessed as a full pathway rather than one gene.
Want to see how your methylation pathway is wired? The Precision Peptide Genetic Test maps named variants in AHCY, MTHFR, and the wider methylation cycle, giving you pathway-level insight to discuss with a provider.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.
This article is part of the PlexusDx Education Hub. Browse all Methylation & MTHFR education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
CRHR1 Gene and Mental Health: What the Research Shows
Genetic origins and effective management of dysphagia?